amg509 now has a name:Xaluritamig

So I was browsing around the internet looking for information about amg509 (a BiTE molecule) and discovered that it has a name now.

Xaluritamig

In Amgens financial report it says that “Initial data demonstrating responses will be presented at an upcoming medical congress.”

amgen.com/newsroom/press-re...

[donits]

This is very interesting, thank you. Czy pamietasz jeszcze jezyk polski?

[Hidden in reply to donits]

nie, moi rodzice nigdy mnie tego nie uczyli

[donits in reply to Hidden]

OK, thank you very much. Best greetings.

[mypk]

“Initial data demonstrating responses will be presented at an upcoming medical congress.”

They will do that at the ESMO Congress on the 20th of October 2023.

esmo.org/meeting-calendar/e...

[Maxone73 in reply to mypk]

Together with arx517….let’s hope for the best!

[Scout4answers in reply to mypk]

Just waiting patiently for a drug that is 99% effective at putting P cancer into remission.

[j-o-h-n]

What did I expect short of a new meds tonged twister named Xaluritamig ..... that's right an announcement by our astute member: sszyszkiewicz.

Good Luck, Good Health and Good Humor.

j-o-h-n Saturday 10/15/2023 10:38 PM DST

[Hidden in reply to j-o-h-n]

Clearly not named by someone in marketing

[mypk in reply to Hidden]

Most pharma companies, including Amgen, employ the 'Brand Institute' to assign names to their products. 'Xaluritamig' is no exception. 🙂

brandinstitute.com/experien...